Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX4 | Q99571 | 5/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22600940 | 0.97 | P2RX4 (0.35) | P2RX4 | |
| SCHEMBL26940507 | 0.90 | PGR (0.30) | — | |
| SCHEMBL26940517 | 0.89 | P2RX4 (0.37) | P2RX4MAPTSMN1; SMN2NPSR1 | |
| SCHEMBL25126426 | 0.88 | RARA (0.32) | P2RX4 | |
| SCHEMBL24292617 | 0.88 | P2RX4 (0.30) | P2RX4 | |
| SCHEMBL26940550 | 0.87 | BCHE (0.34) | SMN1; SMN2NPSR1 | |
| SCHEMBL24000100 | 0.87 | — | — | |
| SCHEMBL16889229 | 0.86 | P2RX4 (0.34) | P2RX4MAPTSMN1; SMN2NPSR1 | |
| SCHEMBL22099827 | 0.83 | P2RX4 (0.31) | P2RX4 | |
| SCHEMBL23464406 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230403926-A1 | ORGANIC LIGHT-EMITTING DEVICE WITH IMPROVED LIFESPAN CHARACTERISTICS | UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY (KR) | 2023-12-14 | — | — | US | disclosed |
| US-20230403926-A1 | ORGANIC LIGHT-EMITTING DEVICE WITH IMPROVED LIFESPAN CHARACTERISTICS | UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY (KR) | 2023-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230403926-A1 | ORGANIC LIGHT-EMITTING DEVICE WITH IMPROVED LIFESPAN CHARACTERISTICS | ELP1, ELOVL1, L3MBTL1 | P2RX4 2367/4885MAPT 1186/4885SMN1; SMN2 140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.